---
figid: PMC8941656__Dtsch_Arztebl_Int-118_0847_001
figtitle: Evaluation of Iron Deficiency and Iron Overload
organisms:
- NA
pmcid: PMC8941656
filename: Dtsch_Arztebl_Int-118_0847_001.jpg
figlink: /pmc/articles/PMC8941656/figure/F1/
number: F1
caption: Regulation of systemic iron metabolismThe amount of available iron (center
  and right), inflammatory factors (left), the iron required  for erythropoiesis (right),
  and hormones and growth factors control hepcidin expression.  Replete iron stores
  increase the amount of the cytokine BMP6 (bone morphogenetic  protein 6), which
  together with the coreceptor hemojuvelin (HJV) activates the BMP/SMAD  signaling
  pathway. Hepcidin induces the degradation of ferroportin, thus reducing the release
  of iron from duodenal enterocytes and macrophages of the reticuloendothelial system.  In
  inflammation-related functional iron deficiency, hepcidin expression is increased
  via the JAK2-STAT3 signaling pathway. As a consequence of iron deficiency anemia,
  the kidney  produces erythropoietin, which increases erythropoiesis. Erythroid progenitor
  cells continue to produce erythroferron, which inhibits the BMP/SMAD pathway and
  hepcidin.EPO, erythropoietin; ERFE, erythroferron; FPN, ferroportin; HFE, high Fe
  (iron);  IL6, interleukin 6; JAK, Janus kinase; STAT, signal transducers and activators
  of transcription; SMAD, small-body-size mothers against decapentaplegic homolog
  1;  TFR2, transferrin receptor 2; TSAT, transferrin saturation.
papertitle: The Evaluation of Iron Deficiency and Iron Overload.
reftext: Norbert Gattermann, et al. Dtsch Arztebl Int. 2021 Dec;118(49):847-856.
year: '2021'
doi: 10.3238/arztebl.m2021.0290
journal_title: Deutsches Ã„rzteblatt International
journal_nlm_ta: Dtsch Arztebl Int
publisher_name: Deutscher Arzte Verlag
keywords: ''
automl_pathway: 0.9282076
figid_alias: PMC8941656__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8941656__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8941656__Dtsch_Arztebl_Int-118_0847_001.html
  '@type': Dataset
  description: Regulation of systemic iron metabolismThe amount of available iron
    (center and right), inflammatory factors (left), the iron required  for erythropoiesis
    (right), and hormones and growth factors control hepcidin expression.  Replete
    iron stores increase the amount of the cytokine BMP6 (bone morphogenetic  protein
    6), which together with the coreceptor hemojuvelin (HJV) activates the BMP/SMAD  signaling
    pathway. Hepcidin induces the degradation of ferroportin, thus reducing the release
    of iron from duodenal enterocytes and macrophages of the reticuloendothelial system.  In
    inflammation-related functional iron deficiency, hepcidin expression is increased
    via the JAK2-STAT3 signaling pathway. As a consequence of iron deficiency anemia,
    the kidney  produces erythropoietin, which increases erythropoiesis. Erythroid
    progenitor cells continue to produce erythroferron, which inhibits the BMP/SMAD
    pathway and hepcidin.EPO, erythropoietin; ERFE, erythroferron; FPN, ferroportin;
    HFE, high Fe (iron);  IL6, interleukin 6; JAK, Janus kinase; STAT, signal transducers
    and activators of transcription; SMAD, small-body-size mothers against decapentaplegic
    homolog 1;  TFR2, transferrin receptor 2; TSAT, transferrin saturation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - SLC40A1
  - EPO
  - TIMP1
  - EPX
  - IK
  - DYRK3
  - BMP6
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - HFE
  - TFR2
  - HJV
---
